Perspectives on the etiology of chronic rhinosinusitis: An immune barrier hypothesis

被引:225
作者
Kern, Robert C. [1 ]
Conley, David B. [1 ]
Walsh, William [1 ]
Chandra, Rakesh [1 ]
Kato, Atsushi [2 ]
Tripathi-Peters, Anju [2 ]
Grammer, Leslie C. [2 ]
Scheimer, Robert P. [2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy & Immunol, Chicago, IL 60611 USA
来源
AMERICAN JOURNAL OF RHINOLOGY | 2008年 / 22卷 / 06期
关键词
Adaptive immune system; chronic rhinosinusitis; fungal hypothesis; immune barrier hypothesis; innate immune system; nasal polyps; superantigen hypothesis;
D O I
10.2500/ajr.2008.22.3228
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: Chronic rhinosinusitis (CRS) has been defined as persistent symptomatic inflammation of the nasal and sinus mucosa resulting from the interaction of multiple host and environmental factors. Recent studies have implicated Alternaria fungi or toxigenic Staphylococcus aureus as Critical agents in CRS pathogenesis. The emphasis oil environmental agents in CRS etiology has focused interest toward elimination of those agents as the prime mechanism of therapy. This viewpoint is in marked contrast to the current perspective on some other chronic inflammatory epithelial disorders that afflict the skin, lungs, and gilt, Wherein host factors are believed to predispose to disease expression in the presence of ubiquitous environmental agents. Methods: The current review evaluates CRS etiology from this perspective and considers that CRS develops, in part, as an outcome Of a dysfunctional host response. Specifically, evidence from our laboratory and others Will be reviewed indicating that CRS is associated with a failure of the mechanical and immunologic barriers across the nasal mucosa. The hypothesis would further propose that genetic and epigenetic variation predisposes susceptible individuals to barrier failure in the presence of environmental stress leading to CRS. Results: From this unifying perspective, bacteria and fungi are seen as disease modifiers rather than primary etiologic agents. Conclusion: The goal is to place concepts of CRS pathophysiology in a framework consistent With a current understanding of chronic inflammation in general and epithelial disease in particular.
引用
收藏
页码:549 / 559
页数:11
相关论文
共 95 条
  • [1] Pathogen recognition and innate immunity
    Akira, S
    Uematsu, S
    Takeuchi, O
    [J]. CELL, 2006, 124 (04) : 783 - 801
  • [2] Total and specific IgE in nasal polyps is related to local eosinophilic inflammation
    Bachert, C
    Gevaert, P
    Holtappels, G
    Johansson, SGO
    van Cauwenberge, P
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (04) : 607 - 614
  • [3] Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology
    Benninger, MS
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2003, 129 (03) : S1 - S32
  • [4] A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis
    Bernstein, JM
    Ballow, M
    Schlievert, PM
    Rich, G
    Allen, C
    Dryja, D
    [J]. AMERICAN JOURNAL OF RHINOLOGY, 2003, 17 (06): : 321 - 326
  • [5] Symptom outcomes after endoscopic sinus surgery for chronic rhinosinusitis
    Bhattacharyya, N
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (03) : 329 - 333
  • [6] Influence of polyps on outcomes after endoscopic sinus surgery
    Bhattacharyya, Neil
    [J]. LARYNGOSCOPE, 2007, 117 (10) : 1834 - 1838
  • [7] 'Eosinophilic fungal rhinosinusitis': A common disorder in europe?
    Braun, H
    Buzina, W
    Freudenschuss, K
    Beham, A
    Stammberger, H
    [J]. LARYNGOSCOPE, 2003, 113 (02) : 264 - 269
  • [8] Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis
    Cimmino, M
    Cavaliere, M
    Nardone, M
    Plantulli, A
    Orefice, A
    Esposito, V
    Raia, V
    [J]. CLINICAL OTOLARYNGOLOGY, 2003, 28 (02) : 125 - 132
  • [9] Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators
    Claeys, S
    Van Hoecke, H
    Holtappels, G
    Gevaert, P
    De Belder, T
    Verhasselt, B
    Van Cauwenberge, P
    Bachert, C
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (04) : 467 - 472
  • [10] CONLEY D, 2006, 2006 COMB W MIDDL SE